Skip to main content

Table 7 maspin expression in gastric, pancreatic and gallbladder cancer

From: Role of maspin in cancer

Authors Years N. patients Maspin expression Clinical features/prognosis/predictive factors
Wang et al. 2004 113 (gastric cancer) 50.5% positive maspin Positive maspin = T4: 35.9%, metastasis: 34.3%, subtype diffuse: 42.1%, undifferentiated: 40%
49.5% negative maspin Negative maspin = T4: 64.1%, metastasis: 65.7%, subtype diffuse: 57.9%, undifferentiated: 60%
Lee et al. 2008 152 (gastric cancer) 71.7% positive maspin  
29.3% negative maspin Negative maspin = undifferentiated, high stage, metastasis and invasion depth, positive p53
Liu et al. 2012 102 (pancreatic cancer) 98% positive maspin  
Maas et al. 2001 24 (pancreatic cancer) 96% positive maspin  
5 (PanIn3)
100% positive maspin
Maesawa 2006 69 (cholelithiasis) 14% positive maspin  
14 (cholelitiasis + intestinal metaplasia)
64%positive maspin
Kim et al. 2012 101 (gallbladder cancer) 59.4% positive maspin  
25(adenoma) 100% negative maspin
10 (normal gallbladder)  
    100%negative maspin